佳贝咳喘宁2号治疗慢性喘息性支气管炎急性发作期临床观察  

Clinical Observation of Jiabei Kechuanning No.2 on Acute Episode of Chronic Asthmatic Bronchitis

作　　者：刘琴 钱静燕 冯绍中 LIU Qin QIAN Jingyan FENG Shaozhong(Qingpu District Hospital of Traditional Chinese Medicine of Shanghai, Shanghai 201700, China)

机构地区：[1]上海市青浦区中医医院,上海201700

出　　处：《中国中医急症》2017年第7期1247-1249,共3页Journal of Emergency in Traditional Chinese Medicine

基　　金：上海市青浦区科学技术发展基金项目(青科发2014-06);上海市中医药事业发展三年行动计划资助项目(ZY3-RCPY-2-2075);上海市青浦区卫生计生系统学科建设与人才培养项目(M2015-19)

摘　　要：目的观察佳贝咳喘宁2号治疗慢性喘息性支气管炎急性发作期(风热证)的临床疗效。方法选取162例慢性喘息性支气管炎急性发作期(风热证)作为研究对象随机分为治疗组及对照组各81例,对照组采用西医常规治疗,治疗组在对照组的基础上配合佳贝咳喘宁2号治疗。比较两组的临床疗效。结果两组总有效率相当(P>0.05),但治疗组临床控制率明显高于对照组(P<0.05)。治疗组咳嗽、咯痰、喘息症状改善情况优于对照组(P<0.05)。结论佳贝咳喘宁2号配合西药治疗慢性喘息性支气管炎急性发作期(风热证)能明显改善患者症状,安全有效。Objective： To observe clinical curative effect of Jiabei Kechuanning No.2 on chronic asthmatic bronchitis in acute attack period（wind heat type）. Methods： 162 cases of chronic asthmatic bronchitis in acute attack stage（wind heat type） were randomly divided into the treatment group and the control group,81 cases in each.The control group received routine treatment. The treatment group was treated with Jiabei Kechuanning No.2 on the basis treatment of the control group. The clinical efficacy of the two groups was compared. Results： There was no significant difference between the two groups in the total efficiency（P 0.05）,but the clinical control rate of the treatment group was significantly higher than that of the control group（P 0.05）. The improvement of symptoms of cough,expectoration and wheezing was better than that of the control group,and the difference was statistically significant（P 0.05）. Conclusion： Jiabei Kechuanning No.2 combined with Western medicine on chronic asthmatic bronchitis in acute attack（wind heat type） can significantly improve the symptoms of patients,and the method is safe and effective,suitable for clinical application.

关 键 词：佳贝咳喘宁2号 慢性喘息性支气管炎 风热型 

分 类 号：R562.2[医药卫生—呼吸系统]